Late Breaking Abstract - Temporal relationships of cytokines, chemokines and cellular biomarkers during Human Rhinovirus (HRV) infection in asthmatics

A. Mann (London, United Kingdom), M. Ghebre (London, United Kingdom), A. Bell (London, United Kingdom)

Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Session: Blood eosinophils and more in airway diseases
Session type: Oral Presentation
Number: 3564
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Mann (London, United Kingdom), M. Ghebre (London, United Kingdom), A. Bell (London, United Kingdom). Late Breaking Abstract - Temporal relationships of cytokines, chemokines and cellular biomarkers during Human Rhinovirus (HRV) infection in asthmatics. 3564

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Human rhinovirus (HRV) induced changes in mild asthma: Time course of clinical and inflammatory biomarker changes
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016


Time course relationships of Type 1 and 2 inflammatory and innate immune pathways during Human Rhinovirus (HRV) infection in subjects with asthma
Source: International Congress 2018 – Asthma analysis
Year: 2018


Upregulation of CCL5 production in the airway epithelium at the time of the viral infection
Source: International Congress 2016 – Airway response to infection
Year: 2016


Induced sputum cytokines and chemokines and mechanistic pathways in adult asthma phenotypes
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013

Late Breaking Abstract - Increased type 2 inflammation in patients with asthma post rhinovirus infection
Source: International Congress 2018 – New pharmacological strategies in airway diseases
Year: 2018


Influenza infection of human lung macrophages increases PDL1 expression
Source: Annual Congress 2013 –Viral infections
Year: 2013

Late Breaking Abstract - Enhanced IL-33 response in differentiated human TH2 cells carrying the IL-1RL1 asthma risk genotype
Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Year: 2021


Late Breaking Abstract: Suppressed rhinovirus (RV) induced type III interferon production in alternatively activated macrophages
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010

LATE-BREAKING ABSTRACT: Increased IL-33 expression is related to high levels of TLR-2 and -4 in steroid-free subjects with asthma
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014

Biomass smoke particles induce cytokines and reduce phagocytosis by monocyte-derived macrophages
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014

IP-10 is selectively produced in the airways upon respiratory virus infection
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013


Late Breaking Abstract - SARS-CoV-2 induces hyperinflammation in human macrophages via TLR4
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Year: 2021



IL-33 and TSLP gene expression are increased in response to human rhinovirus 1B in HDM-treated murine bone marrow-derived macrophages
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014

Clinical biomarkers identify T-helper 2 status defined by mucosal CCL26 in the ADEPT-asthma study
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015


Late Breaking Abstract - Human lung microbiota-driven differential innate immune landscape
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021


Late Breaking Abstract - The pro-inflammatory activity and role of NLRP3 inflammasome in severe influenza A virus pneumonia.
Source: Virtual Congress 2021 – Respiratory failure in COVID19 and beyond
Year: 2021


Role of the immunoregulatory microRNA miR-146a in the innate immune response to rhinovirus infection
Source: Annual Congress 2013 –Viral infections: what is new?
Year: 2013


Cytokine production of leukocytes in response to respiratory syncytial virus is suppressed by cigarette smoking and in COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016

Periostin as a biomarker in patients with asthma: Associations with eosinophilia and Th2 response
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015


Late Breaking Abstract - Intra-alveolar neutrophil-derived microvesicles: a biomarker of COPD severity
Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Year: 2018